晚期HIV患者中抗逆转录病毒治疗经历比例高:撒哈拉以南非洲两个站点的住院结局
研究纳入肯尼亚338例和刚果民主共和国411例HIV感染住院患者,评估临床特征与住院结局。两国分别有83.7%和97.3%以晚期疾病入院,晚期患者中35.4%和21.7%为ART初治,住院死亡率分别为17.2%和29.6%。结论认为晚期HIV住院患者常CD4计数低且一线ART失败,需早期识别治疗失败并快速转换二线ART。
要点
- 肯尼亚和刚果(金)HIV住院患者中分别有83.7%和97.3%为晚期疾病。
- 晚期HIV住院患者中分别有35.4%和21.7%为ART初治。
- 住院死亡率分别为17.2%和29.6%,其中48小时内死亡分别占25.9%和22.5%。
核心结论
- 在撒哈拉以南非洲两个不同临床环境中,晚期HIV住院患者常以低CD4计数入院,且常一线ART失败;需要早期识别治疗失败并快速转换二线ART。
研究设计与样本
- 研究纳入肯尼亚和刚果民主共和国队列中年龄≥13岁的HIV感染住院患者,评估临床和人口学特征及住院结局。
- 肯尼亚住院患者在住院期间前瞻性入组;刚果民主共和国患者按研究标准使用常规医疗信息提取相同的回顾性数据。
主要发现
- 肯尼亚338例和刚果民主共和国411例HIV感染患者中,分别有83.7%(95%CI 79.4%-87.3%)和97.3%(95%CI 95.2%-98.5%)以晚期疾病入院(定义为CD4<200 cells/µL或WHO分期3/4期疾病)。
- 晚期HIV住院患者中,肯尼亚35.4%和刚果民主共和国21.7%入院时为ART初治。
- 正在接受治疗的患者中位治疗时间分别为44.1个月(IQR 18.4-90.5)和55.9个月(IQR 28.1-99.6)。
- 肯尼亚和刚果民主共和国住院患者死亡率分别为17.2%(95%CI 13.5%-21.6%)和29.6%(95%CI 25.4%-34.3%),其中分别有25.9%(95%CI 16.0%-39.0%)和22.5%(95%CI 15.8%-31.0%)在48小时内死亡。
临床怎么用
- 作者认为需要早期识别治疗失败并快速转换二线ART。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human immunodeficiency virus (HIV) remains an important cause of hospitalization and death in low- and middle- income countries. Yet morbidity and in-hospital mortality patterns remain poorly characterized, with prior antiretroviral therapy (ART) exposure and treatment failure status largely unknown. METHODS: We studied HIV-infected inpatients aged ≥13 years from cohorts in Kenya and the Democratic Republic of Congo (DRC), assessing clinical and demographic characteristics and hospitalization outcomes. Kenyan inpatients were prospectively enrolled during hospitalization; identical retrospective data were extracted for Congolese patients meeting the study criteria using routine medical information. RESULTS: Among 338 HIV-infected patients in Kenya and 411 in DRC, 83.7% (95% confidence interval [CI], 79.4%-87.3%) and 97.3% (95% CI, 95.2%-98.5%), were admitted with advanced disease (defined as CD4 <200 cells/µL or World Health Organization stage 3/4 illness). Among inpatients with advanced HIV, 35.4% and 21.7% were ART-naive at admission. Patients under care had a median time of 44.1 (interquartile range [IQR], 18.4-90.5) months and 55.9 (IQR, 28.1-99.6) months on treatment; 17.2% (95% CI, 13.5%-21.6%) and 29.6% (95% CI, 25.4%-34.3%) died, 25.9% (95% CI, 16.0%-39.0%) and 22.5% (95% CI, 15.8%-31.0%) of these within 48 hours. CONCLUSIONS: Across 2 diverse clinical contexts in sub-Saharan Africa, advanced HIV inpatients were frequently admitted with low CD4 counts, often failing first-line ART. Earlier identification of treatment failure and rapid switching to second-line ART are needed.
引用
- Ousley J, Niyibizi AA, Wanjala S, et al. High Proportions of Patients With Advanced HIV Are Antiretroviral Therapy Experienced: Hospitalization Outcomes From 2 Sub-Saharan African Sites. Clin Infect Dis. 2018. PMID: 29514239. doi:10.1093/cid/ciy103
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。